Genetic Polymorphisms of Pneumocystis jirovecii in HIV-Positive and HIV-Negative Patients in Northern China

Ting Xue1, Wei-Qin Du2, Wen-Juan Dai1

  • 1NHC Key Laboratory of Pneumoconiosis, Key Laboratory of Prophylaxis and Treatment and Basic Research of Respiratory Diseases of Shanxi Province, Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Shanxi Medical University, Taiyuan, P.R. China.

Insights

Genetic analysis of Pneumocystis jirovecii in pneumonia cases revealed mixed infections in two of three patients. No drug resistance mutations were found in this initial Shanxi Province study.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Genetics

Background:

  • Pneumocystis jirovecii causes severe Pneumocystis pneumonia (PCP) in immunocompromised individuals.
  • Understanding P. jirovecii genetic diversity is crucial for tracking its epidemiology and treatment.

Purpose of the Study:

  • To investigate the genetic polymorphisms of P. jirovecii in PCP patients from Shanxi Province, China.
  • To analyze genetic variations at nuclear and mitochondrial loci and assess potential drug resistance markers.

Main Methods:

  • PCR amplification and sequencing of eight P. jirovecii gene loci (six nuclear, two mitochondrial).
  • Analysis of samples from three PCP patients (two HIV-positive, one HIV-negative).

Main Results:

  • Coinfections with multiple P. jirovecii genotypes were observed in two patients (one HIV-negative, one HIV-positive) at specific loci.
  • The third patient (HIV-positive) presented a single genotype infection across all analyzed loci.
  • No mutations associated with drug resistance were detected in key drug target genes (dhfr, dhps, cyb).

Conclusions:

  • This study provides the first report on P. jirovecii genetic polymorphisms in PCP patients in Shanxi Province.
  • Findings highlight the presence of genetic diversity and coinfections of P. jirovecii in this region.
  • Further research is needed to understand the clinical implications of P. jirovecii genetic diversity in China.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
650
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
3.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.1K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K